OKEX teams with ALLIVE for 2nd OK Jumpstart project

(source: Unsplash/Joshua Coleman)

Updated on

Malta-based digital asset exchange OKEx will launch its second OK Jumpstart project, ALLIVE (ALV), and will launch its related token sale tomorrow, 16 May 2019, according to a press statement.

ALLIVE is an “intelligent healthcare ecosystem based on blockchain technology”, which aims to provide standardised formats for health data integration, to support high user concurrency, to protect data privacy via decentralised and encrypted storage, and to support extension compatibility, the press statement describes.

The ALLIVE team has been in partnership with Ontology since August 2018 to facilitate inter-business collaboration and data sharing. Such partnership aims to develop a decentralized healthcare ecosystem and a smart blockchain network, according to the company.

“As always, OK Jumpstart weighs the potential of each supporting projects and ALLIVE simply captures the essences of blockchain technology by applying it to new use cases. It sets a good example in demonstrating how the technology can transform healthcare procedures and improve our lives, such as making electronic medical records more readily available for doctors to access without sacrificing the security of our personal data,” said Andy Cheung, Head of Operations of OKEx.

“We have experienced tremendous growth that the blockchain technology brings to our financial system, but the power of blockchain is limitless. We can also use it to establish a sustainable smart health community to enhance the healthcare ecosystem so it can be more accessible and more affordable for everyone,” the OKEx chief added.

The companies say that the ageing population faces a greater prevalence of chronic diseases or new diseases, and costly medical solutions or targeted treatments might not be an affordable option for everyone. With the ever-rising healthcare cost, the companies hope that by adopting blockchain technology can effectively minimise the struggle of managing medical and financial challenges.

- Advertisement -